nodes	percent_of_prediction	percent_of_DWPC	metapath
Theobromine—ADORA1—midbrain—Gilles de la Tourette syndrome	0.0685	0.109	CbGeAlD
Theobromine—ADORA2A—nervous system—Gilles de la Tourette syndrome	0.0652	0.104	CbGeAlD
Theobromine—ADORA2A—central nervous system—Gilles de la Tourette syndrome	0.0628	0.1	CbGeAlD
Theobromine—ADORA1—nervous system—Gilles de la Tourette syndrome	0.0563	0.0898	CbGeAlD
Theobromine—ADORA1—central nervous system—Gilles de la Tourette syndrome	0.0542	0.0865	CbGeAlD
Theobromine—PDE4B—midbrain—Gilles de la Tourette syndrome	0.0507	0.0808	CbGeAlD
Theobromine—ADORA2A—brain—Gilles de la Tourette syndrome	0.0499	0.0795	CbGeAlD
Theobromine—ADORA1—brain—Gilles de la Tourette syndrome	0.0431	0.0687	CbGeAlD
Theobromine—ADORA1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0426	0.114	CbGpPWpGaD
Theobromine—PDE4B—nervous system—Gilles de la Tourette syndrome	0.0417	0.0664	CbGeAlD
Theobromine—PDE4B—central nervous system—Gilles de la Tourette syndrome	0.0401	0.064	CbGeAlD
Theobromine—ADORA2A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0329	0.0882	CbGpPWpGaD
Theobromine—PDE4B—brain—Gilles de la Tourette syndrome	0.0318	0.0508	CbGeAlD
Theobromine—ADORA2A—Monoamine Transport—SLC6A3—Gilles de la Tourette syndrome	0.0265	0.071	CbGpPWpGaD
Theobromine—CYP2E1—nervous system—Gilles de la Tourette syndrome	0.023	0.0367	CbGeAlD
Theobromine—CYP2E1—central nervous system—Gilles de la Tourette syndrome	0.0222	0.0353	CbGeAlD
Theobromine—CYP2E1—brain—Gilles de la Tourette syndrome	0.0176	0.0281	CbGeAlD
Theobromine—ADORA2A—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.0125	0.0334	CbGpPWpGaD
Theobromine—ADORA2A—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.0121	0.0324	CbGpPWpGaD
Theobromine—ADORA1—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.00856	0.023	CbGpPWpGaD
Theobromine—ADORA1—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.00831	0.0223	CbGpPWpGaD
Theobromine—ADORA2A—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.0079	0.0212	CbGpPWpGaD
Theobromine—ADORA1—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.00775	0.0208	CbGpPWpGaD
Theobromine—ADORA1—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00756	0.0203	CbGpPWpGaD
Theobromine—ADORA1—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00734	0.0197	CbGpPWpGaD
Theobromine—ADORA1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00701	0.0188	CbGpPWpGaD
Theobromine—ADORA1—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00684	0.0183	CbGpPWpGaD
Theobromine—ADORA1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00681	0.0183	CbGpPWpGaD
Theobromine—ADORA2A—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.00661	0.0177	CbGpPWpGaD
Theobromine—ADORA2A—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.00642	0.0172	CbGpPWpGaD
Theobromine—ADORA1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00634	0.017	CbGpPWpGaD
Theobromine—ADORA1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00601	0.0161	CbGpPWpGaD
Theobromine—ADORA2A—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.00598	0.016	CbGpPWpGaD
Theobromine—ADORA1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00583	0.0156	CbGpPWpGaD
Theobromine—ADORA1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00543	0.0146	CbGpPWpGaD
Theobromine—ADORA2A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00542	0.0145	CbGpPWpGaD
Theobromine—ADORA2A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00526	0.0141	CbGpPWpGaD
Theobromine—ADORA2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.0049	0.0131	CbGpPWpGaD
Theobromine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00464	0.0124	CbGpPWpGaD
Theobromine—ADORA1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00458	0.0123	CbGpPWpGaD
Theobromine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.0045	0.0121	CbGpPWpGaD
Theobromine—ADORA1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00444	0.0119	CbGpPWpGaD
Theobromine—ADORA1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00444	0.0119	CbGpPWpGaD
Theobromine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.0042	0.0113	CbGpPWpGaD
Theobromine—ADORA1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00414	0.0111	CbGpPWpGaD
Theobromine—ADORA1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00381	0.0102	CbGpPWpGaD
Theobromine—ADORA2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00353	0.00947	CbGpPWpGaD
Theobromine—ADORA2A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00343	0.0092	CbGpPWpGaD
Theobromine—ADORA2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00343	0.0092	CbGpPWpGaD
Theobromine—ADORA2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.0032	0.00857	CbGpPWpGaD
Theobromine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00294	0.00788	CbGpPWpGaD
Theobromine—ADORA1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.0029	0.00777	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00259	0.00693	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00256	0.00685	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00251	0.00673	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00248	0.00665	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00235	0.0063	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00234	0.00627	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00232	0.00622	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00231	0.0062	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00228	0.00611	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00225	0.00604	CbGpPWpGaD
Theobromine—ADORA2A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00224	0.006	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00212	0.00569	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.0021	0.00563	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.002	0.00535	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00194	0.0052	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00181	0.00486	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00181	0.00484	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00176	0.00472	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00164	0.0044	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00164	0.00439	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00162	0.00434	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—HDC—Gilles de la Tourette syndrome	0.00156	0.00419	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00149	0.00399	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00147	0.00394	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00139	0.00372	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00137	0.00368	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00135	0.00361	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00133	0.00357	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00126	0.00339	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00125	0.00336	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00124	0.00332	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00115	0.00308	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00107	0.00287	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00104	0.00279	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000969	0.0026	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—HDC—Gilles de la Tourette syndrome	0.00094	0.00252	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000879	0.00236	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000868	0.00233	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000678	0.00182	CbGpPWpGaD
